Kostas C. Siamopoulos, MD, FRSH, Chariklia Gouva, MD, Konstantinos P

Slides:

Advertisements

Similar presentations

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

Advertisements

The Epidemiology of Hemoglobin Levels in Patients With Type 2 Diabetes

Renal Function Testing

Peritoneal dialysis American Journal of Kidney Diseases

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Citrate Plasma Levels in Patients Under Regional Anticoagulation in Continuous Venovenous Hemofiltration Gerd R. Hetzel, MD, Gediz Taskaya, Christoph.

Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N

Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD

Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD

Impact of Comorbidities on Mortality in Managed Care Patients With CKD

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

What Is the Goal With Endogenous Filtration Markers—Estimation of GFR or Prediction of Kidney Outcomes? Andrew D. Rule, MD, MSc, Kent R. Bailey, PhD,

Evaluation of the Potential Living Kidney Donor

Hai-yan Wang, MD, American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Salt and Hypertension American Journal of Kidney Diseases

J-Shaped Mortality Relationship for Uric Acid in CKD

Effect of Fish Oil on Vitamin D Absorption

Karl D. Nolph, MD, American Journal of Kidney Diseases

The Use of N-of-1 Trials to Individualize Treatment in Patients With Renal Magnesium Wasting Anneke P. Bech, MD, Jack F.M. Wetzels, MD, Hans Groenewoud,

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Nosratola D. Vaziri, MD American Journal of Kidney Diseases

Geriatrics American Journal of Kidney Diseases

Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States Mae Thamer, PhD, Yi Zhang, DDS, MS,

Usability Testing and Acceptance of an Electronic Medication Inquiry System for CKD Patients Clarissa J. Diamantidis, MD, MHS, Marni Zuckerman, MA, Wanda.

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

High Prevalence and Low Awareness of CKD in Taiwan: A Study on the Relationship Between Serum Creatinine and Awareness From a Nationally Representative.

CPR 1.2.: Evaluation of Anemia in CKD

Parathyromatosis and the Challenge of Treatment

A Role for Bromine Deficiency in Sleep Disturbances of Long-Term Dialysis Patients Caterina Canavese, MD, Ester De Costanzi, MD, Piero Stratta, MD, Enrico.

Salicylate Intoxication as a Cause of Pseudohyperchloremia

American Journal of Kidney Diseases

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

The Association of Lipid-Modifying Medications With Mortality in Patients on Long-Term Peritoneal Dialysis Alexander S. Goldfarb-Rumyantzev, MD, PhD,

Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis Peter Heering, MD, Norbert Braun, MD, Reinhard Müllejans,

Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD

Erratum American Journal of Kidney Diseases

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Risk for Incident Renal Dialysis in a Managed Care Population

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Ticagrelor in Clopidogrel-Resistant Patients Undergoing Maintenance Hemodialysis Dimitrios Alexopoulos, MD, FESC, Ioanna Xanthopoulou, MD, Theodora-Eleni.

Arnold S. Relman, MD, American Journal of Kidney Diseases

Trial Quality in Nephrology: How Are We Measuring Up?

Removal of Dabigatran by Hemodialysis

Making Music American Journal of Kidney Diseases

Differences in Blood Transfusion Trends Between US and UK Centers

Erratum American Journal of Kidney Diseases

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Volume 68, Issue 1, Pages (July 2005)

Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKD Evangelia Dounousi, MD, Eleni Papavasiliou, MSc, Areti Makedou, MD, Kyriakos Ioannou,

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Supportive care for patients with renal disease: Time for action

Soluble CD14 and Endotoxin Levels in Hemodialysis Patients: A Tale of 2 Molecules Victor F. Seabra, MD, George Thomas, MD, MPH, Bertrand L. Jaber, MD,

Quiz Page June 2011 American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

III. Treating dyslipidemias

Dialysis Research and N-of-1 Trials: Made for Each Other?

Quiz Page January 2010 American Journal of Kidney Diseases

Serum Leptin and Epoetin Sensitivity

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

James A. Sloand, MD, Mark A. Shelly, MD

Medication Adherence Behavior and Priorities Among Older Adults With CKD: A Semistructured Interview Study Dena E. Rifkin, MD, MS, M. Barton Laws, PhD,

Presentation transcript:

Long-Term Treatment With EPO Increases Serum Levels of High-Density Lipoprotein in Patients With CKD Kostas C. Siamopoulos, MD, FRSH, Chariklia Gouva, MD, Konstantinos P. Katopodis, MD, Christos Tzallas, Peter Nikolopoulos, Eleni C. Papavasiliou, MSc, Alexandros D. Tselepis, MD, PhD American Journal of Kidney Diseases Volume 48, Issue 2, Pages 242-249 (August 2006) DOI: 10.1053/j.ajkd.2006.04.071 Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 1 Bar graph shows serum HDL-C levels in patients with CKD during follow-up. To convert HDL-C in mg/dL to mmol/L, multiply by 0.02586. American Journal of Kidney Diseases 2006 48, 242-249DOI: (10.1053/j.ajkd.2006.04.071) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 2 Correlation between increase in hemoglobin (Hb) levels and increase in HDL-C levels in patients with CKD treated with EPO. American Journal of Kidney Diseases 2006 48, 242-249DOI: (10.1053/j.ajkd.2006.04.071) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions